Commissioner of health direction to study and report on activities to support innovations in cell and gene therapy to treat rare diseases

Summary

The bill directs the Minnesota Commissioner of Health, in consultation with the University of Minnesota, the Rare Disease Advisory Council, and other stakeholders, to conduct a comprehensive study of the state's ability to research, develop, deliver, and fund cell and gene therapies for rare diseases. By Jan. 1, 2028 the commissioner must submit a report with findings, recommendations, and potential funding opportunities. The measure aims to identify gaps and guide future state actions to support these advanced treatments.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share